Psilocybin study probes Inflammation's role in depression recovery
NCT ID NCT07164755
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 30 times
Summary
This study looks at blood samples from 46 people with treatment-resistant depression who took psilocybin in a previous trial. Researchers want to see if inflammation levels in the blood before and after treatment are linked to how well the depression improves. The goal is to better understand why psilocybin works for some people and not others, which could help doctors personalize future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
King's College London Institute of Psychiatry, Psychology and Neuroscience
London, SE5 8AF, United Kingdom
Conditions
Explore the condition pages connected to this study.